Although, the prognostic significance of HER-2 status in patients with gastric cancer is unclear [19,20], systematic reviews and meta-analyses have shown that MSI-H and EBV-positive gastric cancers are associated with longer survival times and good prognosis [[21], [22], [23]]. This evidence concerns the gene ERBB2 and gastric cancer.